DSTYK and colorectal carcinoma: DSTYK expression is positively proportional to the expression of TGF-β, mesenchymal markers vimentin (VIM) and N-cadherin (CDH2) (Figures 1A, B, D) in tumor tissues from human CRC patients, whereas it is inversely correlated to epithelial marker E-cadherin (CDH1) expression (Figure 1C).